2000027

Phase I/II safety and immunogenicity studies of Peru 15, a live attenuated oral vaccine candidate for vibro cholerae O1 in Bangladeshi volunteers both adults and children

Short Title P/II safety & immunogenicity studies of peru 15
Protocol No 2000027
Status Completed
Keywords LIVE ORAL CHOLERA VACCINE; SAFETY; IMMUNOGENICITY
Center Laboratory Sciences
MDG(s) this protocol relates to
HPNSDP(s) this protocol relates to
PI Name Firdausi Qadri
Collaborating Institutes (020) Children's Hospital Medical Centre, Ohio
(042) Harvard Medical School, Boston, USA
(145) University of Cincinnati, Ohio
Funding
Summary
‹ Search All Protocols Here